Index -
P/E -
EPS (ttm) -0.34
Insider Own 42.81%
Shs Outstand 63.27M
Perf Week 0.79%
Market Cap 407.24M
Forward P/E 14.28
EPS next Y 0.45
Insider Trans -0.07%
Shs Float 36.22M
Perf Month 0.47%
Income -21.65M
PEG -
EPS next Q 0.07
Inst Own 33.32%
Short Float 1.63%
Perf Quarter 17.06%
Sales 522.74M
P/S 0.78
EPS this Y 1281.66%
Inst Trans 2.03%
Short Ratio 2.10
Perf Half Y 32.92%
Book/sh 2.69
P/B 2.37
EPS next Y 61.73%
ROA -2.57%
Short Interest 0.59M
Perf Year 93.33%
Cash/sh 0.39
P/C 16.18
EPS next 5Y -
ROE -12.03%
52W Range 2.70 - 7.04
Perf YTD 21.06%
Dividend Est. -
P/FCF 257.74
EPS past 5Y -51.10%
ROI -4.04%
52W High -9.37%
Beta 0.87
Dividend TTM -
Quick Ratio 0.97
Sales past 5Y 10.81%
Gross Margin 63.93%
52W Low 136.30%
ATR (14) 0.38
Dividend Ex-Date Mar 26, 2004
Current Ratio 1.53
EPS Y/Y TTM 92.57%
Oper. Margin 6.48%
RSI (14) 53.48
Volatility 5.63% 5.75%
Employees 970
Debt/Eq 2.36
Sales Y/Y TTM 1.72%
Profit Margin -4.14%
Recom 2.33
Target Price 8.50
Option/Short Yes / Yes
LT Debt/Eq 2.13
EPS Q/Q 96.78%
Payout -
Rel Volume 0.90
Prev Close 6.54
Sales Surprise 9.37%
EPS Surprise 204.95%
Sales Q/Q 8.73%
Earnings May 07 BMO
Avg Volume 281.02K
Price 6.38
SMA20 -2.83%
SMA50 16.95%
SMA200 40.40%
Trades
Volume 252,879
Change -2.45%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-07-23 Upgrade
Canaccord Genuity
Hold → Buy
$7
Aug-09-23 Upgrade
Craig Hallum
Hold → Buy
$4 → $6
Nov-22-22 Downgrade
Craig Hallum
Buy → Hold
Nov-09-22 Downgrade
JP Morgan
Overweight → Underweight
Nov-09-22 Downgrade
Canaccord Genuity
Buy → Hold
$18 → $6
Mar-15-22 Initiated
Craig Hallum
Buy
$30
Nov-15-21 Resumed
Morgan Stanley
Overweight
$20
Nov-10-21 Resumed
JP Morgan
Overweight
$25
Jul-01-21 Downgrade
Goldman
Buy → Neutral
$20 → $19
Mar-08-21 Initiated
Morgan Stanley
Overweight
$18
Mar-08-21 Initiated
JP Morgan
Overweight
$17
Mar-08-21 Initiated
Goldman
Buy
$19
Mar-08-21 Initiated
Canaccord Genuity
Buy
$23
Show Previous Ratings
Jun-05-24 10:17AM
May-23-24 06:42AM
May-09-24 07:29AM
May-08-24 12:28PM
03:19AM
11:41PM
Loading…
May-07-24 11:41PM
(Thomson Reuters StreetEvents) +28.00%
07:00AM
Apr-29-24 07:30AM
Mar-13-24 08:48AM
Mar-12-24 10:20PM
(Thomson Reuters StreetEvents) +5.46%
09:11AM
07:30AM
Mar-04-24 08:00AM
Jan-18-24 04:15PM
Jan-12-24 04:15PM
04:30PM
Loading…
Dec-19-23 04:30PM
Dec-06-23 08:00AM
Nov-27-23 01:33AM
Nov-12-23 09:02AM
Nov-07-23 07:59AM
07:00AM
Oct-31-23 07:00AM
Oct-25-23 10:48AM
Sep-28-23 07:43AM
Sep-19-23 09:52PM
Sep-06-23 04:30PM
Aug-16-23 09:02AM
Aug-10-23 08:09AM
(American City Business Journals) +11.74%
Aug-08-23 10:02PM
(Thomson Reuters StreetEvents) +14.12%
07:30AM
08:30AM
Loading…
Aug-04-23 08:30AM
Aug-01-23 05:35PM
Jun-23-23 06:35PM
May-25-23 06:38AM
May-23-23 07:30AM
May-18-23 12:07PM
May-17-23 08:33AM
(Thomson Reuters StreetEvents) +9.17%
May-16-23 04:15PM
May-15-23 05:33PM
May-11-23 07:00AM
May-10-23 09:00AM
May-03-23 08:30AM
Apr-08-23 08:55AM
Apr-05-23 10:52AM
08:00AM
07:38AM
Mar-31-23 07:30AM
07:00AM
Mar-30-23 04:51AM
Mar-29-23 08:55AM
Mar-20-23 10:16AM
Mar-16-23 08:30AM
Feb-28-23 07:30AM
Jan-27-23 02:49PM
(American City Business Journals)
Jan-14-23 03:14PM
Jan-04-23 07:00AM
Dec-27-22 02:53PM
(American City Business Journals)
Dec-09-22 11:58AM
(American City Business Journals)
Nov-28-22 10:34PM
(American City Business Journals) -20.41%
Nov-21-22 05:15PM
Nov-16-22 05:15PM
Nov-10-22 05:38AM
(Simply Wall St.) +25.58%
Nov-09-22 06:18PM
Nov-08-22 07:30AM
Oct-31-22 07:00AM
Oct-12-22 08:00AM
Aug-30-22 08:00AM
Aug-12-22 02:32AM
Aug-11-22 07:00AM
Aug-03-22 07:00AM
Jul-26-22 07:00AM
Jul-12-22 08:30AM
Jul-04-22 10:00AM
Jun-22-22 05:00AM
(American City Business Journals)
Jun-21-22 07:30AM
Jun-15-22 08:33AM
May-10-22 01:00PM
07:00AM
May-04-22 02:54PM
(American City Business Journals) -10.41%
05:56AM
May-03-22 05:47PM
01:57PM
May-02-22 07:00AM
Apr-26-22 02:59PM
(American City Business Journals)
09:05AM
08:38AM
Apr-25-22 07:00AM
Apr-08-22 09:15AM
Apr-07-22 10:12PM
Apr-05-22 07:00AM
Apr-04-22 05:36PM
02:23PM
(American City Business Journals)
11:27AM
07:00AM
Apr-03-22 09:10PM
Mar-25-22 07:32AM
(American City Business Journals)
Mar-16-22 07:00AM
Mar-11-22 09:43AM
Mar-10-22 12:30PM
07:00AM
Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
STALNECKER SUSAN M Director Jun 07 '24 Option Exercise 0.00 30,400 0 79,464 Jun 11 08:46 PM SUTTER MARTIN P Director Jun 07 '24 Option Exercise 0.00 30,400 0 58,748 Jun 11 08:47 PM NEELS GUIDO J Director Jun 07 '24 Option Exercise 0.00 30,400 0 58,748 Jun 11 08:45 PM NOHRA GUY P Director Jun 07 '24 Option Exercise 0.00 30,400 0 100,117 Jun 11 08:46 PM Ladone Mary Kay Director Jun 07 '24 Option Exercise 0.00 30,400 0 50,674 Jun 11 08:44 PM HAWKINS WILLIAM A Director Jun 07 '24 Option Exercise 0.00 30,400 0 231,358 Jun 11 08:45 PM Beyer Pat Director Jun 07 '24 Option Exercise 0.00 30,400 0 48,978 Jun 11 08:43 PM McMurry-Heath Michelle Director Jun 07 '24 Option Exercise 0.00 30,400 0 47,819 Jun 11 08:44 PM Bartholdson John A. Director Jun 07 '24 Option Exercise 0.00 30,400 0 45,552 Jun 11 08:43 PM Bartholdson John A. Director Jun 06 '24 Option Exercise 0.00 7,576 0 15,152 Jun 10 05:40 PM Singleton Mark Leonard SVP & CFO Apr 11 '24 Sale 4.75 4,000 19,000 34,665 Apr 15 06:03 PM D'Adamio Anthony SVP & General Counsel Apr 11 '24 Sale 4.75 3,054 14,506 58,242 Apr 15 06:00 PM CHURCH KATRINA J SVP & Chief Compliance Officer Apr 11 '24 Sale 4.75 1,325 6,294 17,042 Apr 15 05:58 PM Singleton Mark Leonard SVP & CFO Mar 22 '24 Sale 5.39 5,541 29,853 25,665 Mar 25 05:36 PM D'Adamio Anthony SVP & General Counsel Mar 15 '24 Sale 5.46 3,125 17,062 51,371 Mar 20 06:41 PM CHURCH KATRINA J SVP & Chief Compliance Officer Mar 15 '24 Sale 5.46 1,217 6,645 14,067 Mar 20 06:41 PM Bihl Anthony P III Interim CEO Aug 18 '23 Buy 4.14 26,595 110,071 26,595 Aug 22 06:20 PM Bihl Anthony P III Interim CEO Aug 18 '23 Buy 4.14 13,290 55,005 138,290 Aug 22 06:20 PM Juniper Investment Company, LL 10% Owner Aug 14 '23 Buy 4.79 14,985 71,778 6,833,857 Aug 15 04:05 PM Bartholdson John A. Director Aug 14 '23 Buy 4.79 14,985 71,753 6,833,857 Aug 15 05:48 PM Bartholdson John A. Director Aug 11 '23 Buy 4.60 50,037 229,935 6,818,872 Aug 15 05:48 PM Juniper Investment Company, LL 10% Owner Aug 11 '23 Buy 4.56 50,037 228,169 6,818,872 Aug 15 04:05 PM Bartholdson John A. Director Aug 10 '23 Buy 4.47 111,848 500,419 6,768,835 Aug 14 06:04 PM Juniper Investment Company, LL 10% Owner Aug 10 '23 Buy 4.47 111,848 499,961 6,768,835 Aug 15 04:05 PM CHURCH KATRINA J SVP & Chief Compliance Officer Jul 03 '23 Sale 2.83 394 1,115 11,828 Jul 05 05:11 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite